Pharming Group(DE:PHG)
€11.20-0.20 (-1.75%)
DE:PHG
Pharming Group financials statements
€11.20
At close:-0.20 (-1.75%)
Pharming Group (PHG) Income Statement
0 Followers
Pharming Group Income Statement
Last quarter (Q3 2026), Pharming Group's total revenue was €117.56M, an increase of 20.84% from the same quarter last year. In Q3, Pharming Group's net income was €22.43M. See Pharming Group’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 376.13M | € 297.20M | € 245.32M | € 205.62M | € 198.87M | |
| € 330.63M | € 261.80M | € 220.10M | € 188.06M | € 177.73M | |
| € 309.75M | € 265.47M | € 242.39M | € 178.20M | € 158.72M | |
| Depreciation and Amortization | € 11.22M | € 16.07M | € 15.93M | € 13.19M | € 19.61M |
| € 34.78M | € 16.32M | € 9.88M | € 33.53M | € 48.78M | |
| € 20.88M | € -3.67M | € -22.29M | € 9.86M | € 19.01M | |
| € -8.03M | € -4.83M | € 10.28M | € 5.13M | € 4.07M | |
| € 12.85M | € -8.49M | € -12.01M | € 14.99M | € 23.08M | |
| € 2.85M | € -11.84M | € -10.55M | € 13.67M | € 16.00M | |
| Per Share Metrics | |||||
| Basic EPS | € 0.04 | € -0.18 | € -0.14 | € 0.17 | € 0.23 |
| Diluted EPS | € 0.04 | € -0.18 | € -0.14 | € 0.16 | € 0.21 |
| Weighted Average Shares Outstanding | 71.32M | 68.92M | 65.70M | 82.54M | 87.64M |
| Weighted Average Shares Outstanding (Diluted) | 71.32M | 68.92M | 65.70M | 84.28M | 87.64M |
Currency in EUR

